These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15749920)

  • 21. The complexicity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats.
    Xu LY; Ishikawa M; Huang YM; Levi M; van der Meide PH; Wahren B; Link H; Xiao BG
    Clin Immunol; 2000 Apr; 95(1 Pt 1):70-8. PubMed ID: 10794434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
    Hofstetter HH; Shive CL; Forsthuber TG
    J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active immunization using a single dose immunotherapeutic abates established EAE via IL-10 and regulatory T cells.
    Rynda-Apple A; Huarte E; Maddaloni M; Callis G; Skyberg JA; Pascual DW
    Eur J Immunol; 2011 Feb; 41(2):313-23. PubMed ID: 21268002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide.
    Marusić S; Tonegawa S
    J Exp Med; 1997 Aug; 186(4):507-15. PubMed ID: 9254649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10.
    Braciak TA; Pedersen B; Chin J; Hsiao C; Ward ES; Maricic I; Jahng A; Graham FL; Gauldie J; Sercarz EE; Kumar V
    J Immunol; 2003 Jan; 170(2):765-74. PubMed ID: 12517939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate.
    Soos JM; Stüve O; Youssef S; Bravo M; Johnson HM; Weiner HL; Zamvil SS
    J Immunol; 2002 Sep; 169(5):2231-5. PubMed ID: 12193686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of Th2 cytokine increase during spontaneous remission of experimental allergic encephalomyelitis.
    Di Rosa F; Francesconi A; Di Virgilio A; Finocchi L; Santilio I; Barnaba V
    Eur J Immunol; 1998 Dec; 28(12):3893-903. PubMed ID: 9862326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
    Cua DJ; Coffman RL; Stohlman SA
    J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
    J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-2/neuroantigen fusion proteins as antigen-specific tolerogens in experimental autoimmune encephalomyelitis (EAE): correlation of T cell-mediated antigen presentation and tolerance induction.
    Mannie MD; Clayson BA; Buskirk EJ; DeVine JL; Hernandez JJ; Abbott DJ
    J Immunol; 2007 Mar; 178(5):2835-43. PubMed ID: 17312127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting autoantigen-specific T cells and suppression of autoimmune encephalomyelitis with receptor-modified T lymphocytes.
    Jyothi MD; Flavell RA; Geiger TL
    Nat Biotechnol; 2002 Dec; 20(12):1215-20. PubMed ID: 12426577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimethyl fumarate-induced IL-17
    Brück J; Glocova I; Geisel J; Kellerer C; Röcken M; Ghoreschi K
    Eur J Immunol; 2018 Sep; 48(9):1588-1591. PubMed ID: 30007005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression.
    Chen Y; Inobe J; Weiner HL
    J Immunol; 1995 Jul; 155(2):910-6. PubMed ID: 7541826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation.
    Samoilova EB; Horton JL; Zhang H; Chen Y
    J Mol Med (Berl); 1997 Aug; 75(8):603-8. PubMed ID: 9297628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.
    Burkhart C; Liu GY; Anderton SM; Metzler B; Wraith DC
    Int Immunol; 1999 Oct; 11(10):1625-34. PubMed ID: 10508180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells.
    Ria F; Penna G; Adorini L
    Eur J Immunol; 1998 Jun; 28(6):2003-16. PubMed ID: 9645382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit.
    Costa GL; Sandora MR; Nakajima A; Nguyen EV; Taylor-Edwards C; Slavin AJ; Contag CH; Fathman CG; Benson JM
    J Immunol; 2001 Aug; 167(4):2379-87. PubMed ID: 11490028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.